Pharmacokinetics and concentration-control investigations of mycophenolic acid in adults after transplantation.
about
Evaluation of Mycophenolate Mofetil and Low-Dose Steroid Combined Therapy in Moderately Severe Henoch-Schönlein Purpura Nephritis.Pharmacokinetics of mycophenolic acid in patients with lupus nephritis.Pharmacokinetics of mycophenolic acid in Chinese kidney transplant patientsImmunosuppressive therapy and post-transplantation diarrhea.Mycophenolate mofetil in solid-organ transplantation.Mycophenolic acid pharmacokinetics and related outcomes early after renal transplantInvestigation on pharmacokinetics of mycophenolic acid in Chinese adult renal transplant patientsPharmacokinetic principles of immunosuppressive drugs.A Protocol for the Pharmacokinetics of Enteric Coated Mycophenolate Sodium in Lupus Nephritis (POEMSLUN): an open-label, randomised controlled trialInosine monophosphate dehydrogenase (IMPDH) activity as a pharmacodynamic biomarker of mycophenolic acid effects in pediatric kidney transplant recipients.Influence of clinical and demographic variables on mycophenolic acid pharmacokinetics in antineutrophil cytoplasmic antibody-associated vasculitis.Pharmacogenetic influences on mycophenolate therapy.Drug choices in autoimmune hepatitis: part B--Nonsteroids.Limited sampling strategy for predicting area under the concentration-time curve of mycophenolic acid in adult lung transplant recipients.Mycophenolate mofetil: long-term outcomes in solid organ transplantation.Variability in free mycophenolic acid exposure in adult liver transplant recipients during the early posttransplantation period.Monitoring trough plasma concentrations of mycophenolate mofetil in patients with uveitis.Pharmacokinetic study of mycophenolic acid in Korean kidney transplant patients.Pre-transplant inosine monophosphate dehydrogenase activity is associated with clinical outcome after renal transplantation.The need of mycophenolic acid monitoring in long-term renal transplants.Limited sampling strategy of mycophenolic acid in adult kidney transplant recipients: influence of the post-transplant period and the pharmacokinetic profile.Mycophenolate mofetil in patients with systemic lupus erythematosus: a prospective pharmacokinetic study.Influence of uridine diphosphate (UDP)-glucuronosyltransferases and ABCC2 genetic polymorphisms on the pharmacokinetics of mycophenolic acid and its metabolites in Chinese renal transplant recipients.Mycophenolate mofetil in islet cell transplant: variable pharmacokinetics but good correlation between total and unbound concentrations.Estimation of the area under the curve for mycophenolic acid in adult renal transplant patients with concomitant tacrolimus using a limited sampling strategy.Comparison of mycophenolic acid pharmacokinetic parameters in kidney transplant patients within the first 3 months post-transplant.Highly variable mycophenolate mofetil bioavailability following nonmyeloablative hematopoietic cell transplantation.
P2860
Q33728060-2959A5AB-A95B-4F75-B7DE-4F9AB6FBFDB7Q33984216-FFD19F9D-E3B1-46B4-B665-184C8D56C637Q34425701-86E0EEDA-7132-4237-9BA4-86336D2DC6C3Q34485488-CC433C79-443B-4FA8-9F0D-3BE63837C284Q35594016-F42BEC06-6CA2-427A-B0C1-FE1360C4F384Q35826828-5903ADDE-659B-4677-95CD-E8440FE26BC0Q35827831-E26AEEAC-7107-440D-8D38-8273CEE3BF63Q36006086-58B1C153-6AD2-4DC7-BE90-BE9D1E284A27Q37086991-16DD3A25-C057-4363-B1C5-258F1D2780FFQ37161962-1743F6DC-F6B1-401E-A91E-8E118D64B26BQ37423423-ACE3B701-7B18-4524-97F8-6DA0E40EE9E3Q37710509-10285C31-B650-4C8F-92C6-CA5FC72A197FQ38051706-E5B83E5C-D908-4575-A2BC-6AB6BEA195F1Q42597049-3FAFA43E-0313-4CB6-A5CC-8C46CB2B1910Q43061583-52B68F98-06BC-4537-BD49-02F91F948F80Q43166785-300F18B9-16C5-4DB4-83B8-C30FC76A5BEAQ44746160-42E85474-6204-45F7-ABF9-3E8B33894D01Q44938164-4FEDC8EB-30AF-4F99-A4A9-73D6E4017F60Q45171034-2AE2C6E0-7D00-4081-A3B6-E8F3B6E11277Q45230194-926E652A-C0E9-4CD6-8B43-9237E7715CA3Q45729560-681A2BC9-E89D-4306-8DF6-E3B8F875AE59Q46076329-77C6F77A-965C-427B-BDDD-A06FC411C8ADQ46301017-528D109E-69CB-4E73-B68D-5759B48277D9Q46606996-328405E6-397C-425B-9D39-9373E11AEAB4Q46721834-73110825-E833-4DEE-9AED-9EE05A5CE82EQ46942520-69175620-7CE5-4B19-87A4-B80ADF8CEB4DQ50703377-A2B83659-71A2-4DF8-9ED8-7FEC52E1974A
P2860
Pharmacokinetics and concentration-control investigations of mycophenolic acid in adults after transplantation.
description
2000 nî lūn-bûn
@nan
2000 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Pharmacokinetics and concentra ...... adults after transplantation.
@ast
Pharmacokinetics and concentra ...... adults after transplantation.
@en
type
label
Pharmacokinetics and concentra ...... adults after transplantation.
@ast
Pharmacokinetics and concentra ...... adults after transplantation.
@en
prefLabel
Pharmacokinetics and concentra ...... adults after transplantation.
@ast
Pharmacokinetics and concentra ...... adults after transplantation.
@en
P2093
P1476
Pharmacokinetics and concentra ...... adults after transplantation.
@en
P2093
P356
10.1097/00007691-200002000-00003
P577
2000-02-01T00:00:00Z